Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
[video] Johnson & Johnson CEO on Road Ahead
CNBC
Fri, 02/18/11 - 09:18 am
JNJ
Pharma CEOs
William Weldon
Pipeline at Alkermes Advances
Yahoo/Zacks.com
Thu, 02/17/11 - 07:56 am
Alkermes
Amylin
JNJ
ALKS 37
opiod-induced constipation
Cordis, Bard lay off workers
Mon, 02/14/11 - 04:14 pm
Cordis
C.R. Bard
layoffs
JNJ
J&J's Cordis Unit Reducing Size Of US Sales Force
Thu, 02/10/11 - 05:04 pm
JNJ
Cordis
restructuring
endovascular
FDA OKs generic version of Duragesic pain patch
Yahoo/AP
Thu, 02/10/11 - 10:29 am
Duragesic
pain patches
generics
FDA
Covidien
JNJ
Johnson & Johnson Deal for Crucell Moves Forward
NY Times, NY
Wed, 02/9/11 - 11:49 am
JNJ
vaccines
M&A
Crucell
The Consensus Opinion on Johnson & Johnson: Bullish
Motley Fool
Tue, 02/8/11 - 04:51 pm
JNJ
Drugs for Schizophrenia May Lead to Brain Tissue Loss
Bloomberg
Mon, 02/7/11 - 07:25 pm
JNJ
schizophrenia
AstraZeneca
Risperdal
Zyprexa
Seroquel
Eli Lilly
Boost for Shire's ADHD Franchise
Yahoo/Zacks.com
Mon, 02/7/11 - 07:23 pm
ADHD
Eli Lilly
JNJ
Vyvanase
Jury Nails J&J With $482 Million Patent Infringement Verdict: Biotech's Latest Tribulations
Seeking Alpha
Mon, 02/7/11 - 08:01 am
JNJ
GSK
Pfizer
Teva Pharmaceuticals
Actelion
Risperdal Overcharge Trial Looms Over J&J
The Street
Sat, 02/5/11 - 11:07 am
JNJ
Risperdal
lawsuits
Value Pharma Stocks in Overpriced Market
Seeking Alpha
Sat, 02/5/11 - 10:59 am
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Alkermes Performs Better than Est.
Yahoo/Zacks.com
Fri, 02/4/11 - 11:13 am
earnings
Alkermes
JNJ
Johnson & Johnson: Dividend Stock Analysis
Seeking Alpha
Fri, 02/4/11 - 11:05 am
JNJ
dividends
5 Breakthrough Drugs for 2011
Barron's
Thu, 02/3/11 - 10:06 am
Benlysta
Human Genome Sciences
GSK
ipilimumab
Bristol-Myers Squibb
Vertex Pharmaceuticals
JNJ
Telaprevir
Novartis
Incyte
INCB-18424
Xarelto
Bayer
Abbott and Johnson & Johnson: 2 Dividend Aristocrats for Long-Term Gains
Seeking Alpha
Tue, 02/1/11 - 07:12 am
JNJ
Abbott Laboratories
dividends
Is Johnson & Johnson the Perfect Stock?
Motley Fool
Mon, 01/31/11 - 05:06 pm
JNJ
J&J Signed Remarkable Deal to extend the AIDS Drug Access
TopNews
Sat, 01/29/11 - 12:37 pm
JNJ
AIDS
J&J Hip Replacement Plaintiff Committee Lawyers Named by Judge in Ohio
Bloomberg
Sat, 01/29/11 - 11:54 am
JNJ
lawsuits
Johnson & Johnson Told to Pay New Jersey Doctor $482 Million Over Patent
Bloomberg
Sat, 01/29/11 - 11:47 am
JNJ
lawsuits
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »